Generation of fluorescently labeled tracers – which features influence the translational potential?

EJNMMI Radiopharmacy and Chemistry

Latifa Rbah-Vidal¹  Jacques Barbet¹  Silvana Del Vecchio²  Federico Caobelli³  Bart Cornelissen⁴  Marion de Jong⁵  Catarina Xavier⁶  Fijs W. B. van Leeuwen⁷  Laura Evangelista⁸ 

[1] CRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes;Department of Advanced Biomedical Sciences, University Federico II;Department of Nuclear Medicine, University Hospital Basel;Department of Oncology, CRUK&MRC Oxford Institute for Radiation Oncology, University of Oxford;Department of Radiology & Nuclear Medicine, Erasmus Medical Centre;In vivo Cellular and Molecular Imaging Lab (ICMI)-Department, Vrije Universiteit Brussel;Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center;Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV – IRCCS;

关键词: Fluorescence;    Image guided surgery;    Molecular imaging;    Tracers;    Nuclear medicine;    Dual-modality;   

DOI  :  10.1186/s41181-017-0034-8

来源: DOAJ

【 摘 要 】

Abstract Given the increasing exploration of fluorescent tracers in the field of nuclear medicine, a need has risen for practical development guidelines that can help improve the translation aspects of fluorescent tracers. This editorial discusses the does and don’ts in developing fluorescence tracers. It has been put forward by the European Association of Nuclear Medicine (EANM) Translational Molecular Imaging & Therapy committee and has been approved by the EANM board.

【 授权许可】

Unknown